JPS5738715A - Medical composition having activity of prohibiting artery wall from thickening - Google Patents
Medical composition having activity of prohibiting artery wall from thickeningInfo
- Publication number
- JPS5738715A JPS5738715A JP11311680A JP11311680A JPS5738715A JP S5738715 A JPS5738715 A JP S5738715A JP 11311680 A JP11311680 A JP 11311680A JP 11311680 A JP11311680 A JP 11311680A JP S5738715 A JPS5738715 A JP S5738715A
- Authority
- JP
- Japan
- Prior art keywords
- artery wall
- trapidil
- thickening
- pdgf
- prohibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001367 artery Anatomy 0.000 title abstract 5
- 230000008719 thickening Effects 0.000 title abstract 5
- 230000000694 effects Effects 0.000 title abstract 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 abstract 5
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 abstract 5
- GSNOZLZNQMLSKJ-UHFFFAOYSA-N Trapidil Chemical compound CCN(CC)C1=CC(C)=NC2=NC=NN12 GSNOZLZNQMLSKJ-UHFFFAOYSA-N 0.000 abstract 5
- 229960000363 trapidil Drugs 0.000 abstract 4
- 230000035755 proliferation Effects 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11311680A JPS5738715A (en) | 1980-08-18 | 1980-08-18 | Medical composition having activity of prohibiting artery wall from thickening |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11311680A JPS5738715A (en) | 1980-08-18 | 1980-08-18 | Medical composition having activity of prohibiting artery wall from thickening |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5738715A true JPS5738715A (en) | 1982-03-03 |
| JPS6232722B2 JPS6232722B2 (https=) | 1987-07-16 |
Family
ID=14603910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11311680A Granted JPS5738715A (en) | 1980-08-18 | 1980-08-18 | Medical composition having activity of prohibiting artery wall from thickening |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5738715A (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0682947A1 (en) | 1994-05-19 | 1995-11-22 | Mitsubishi Chemical Corporation | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia |
-
1980
- 1980-08-18 JP JP11311680A patent/JPS5738715A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0682947A1 (en) | 1994-05-19 | 1995-11-22 | Mitsubishi Chemical Corporation | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6232722B2 (https=) | 1987-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE357214T1 (de) | Verwendung eines unverkapselten anti-krebs- wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation | |
| NO155664C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(1,2-a)-pyridiner. | |
| UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| NO20035434D0 (no) | Behandling eller profylakse av transplantasjonsavst degree tning av insulinproduserende celler | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| MY106231A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones. | |
| ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
| NO157377C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazodiazepiner. | |
| DK0856312T3 (da) | Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme | |
| RU98101907A (ru) | Терапевтические агенты и аутоимунные заболевания | |
| RU95113499A (ru) | Способ повышения мочеотделения у человека, способ снижения уровней холестерина и липопротеинов низкой плотности, применение (+) доксазозина | |
| NO164904C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater. | |
| JPS57122085A (en) | Circulatory disease extirpenter and use | |
| ATE44156T1 (de) | Kovalent gebundener heparin-antithrombin iiikomplex, verfahren zu dessen herstellung und seine verwendung zur behandlung von thrombusembolie. | |
| ES8400742A1 (es) | Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co. | |
| Kumar | Extinction of fear I: Effects of amylobarbitone and dexamphetamine given separately and in combination on fear and exploratory behaviour in rats | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| JPS5738715A (en) | Medical composition having activity of prohibiting artery wall from thickening | |
| DK0737475T3 (da) | Anvendelse af en muscarin antagonist til fremstilling af et medikament til behandling og regulering af okular udvikling | |
| UA41329C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії | |
| Selvini Palazzoli et al. | Snares in family therapy. | |
| ATE192040T1 (de) | Wirkstoff gegen arteriosklerose | |
| JPS5630917A (en) | Preventive and remedy for hepatitis | |
| NO20011371L (no) | Kjemokinreseptorantagonist og cyklosporin i kombinert terapi |